Adherence to Survivorship Care Guidelines in Health Care Providers for Non-Small Cell Lung Cancer and Colorectal Cancer Survivor Care
Adenocarcinoma of the Lung
Mucinous Adenocarcinoma of the Colon
Mucinous Adenocarcinoma of the Rectum
Signet Ring Adenocarcinoma of the Colon
Signet Ring Adenocarcinoma of the Rectum
Squamous Cell Lung Cancer
Stage I Colon Cancer
Stage I Rectal Cancer
Stage IA Non-small Cell Lung Cancer
Stage IB Non-small Cell Lung Cancer
Stage IIA Colon Cancer
Stage IIA Non-small Cell Lung Cancer
Stage IIA Rectal Cancer
Stage IIB Colon Cancer
Stage IIB Non-small Cell Lung Cancer
Stage IIB Rectal Cancer
Stage IIC Colon Cancer
Stage IIC Rectal Cancer
Stage IIIA Colon Cancer
Stage IIIA Non-small Cell Lung Cancer
Stage IIIA Rectal Cancer
Stage IIIB Colon Cancer
Stage IIIB Non-small Cell Lung Cancer
Stage IIIB Rectal Cancer
Stage IIIC Colon Cancer
Stage IIIC Rectal Cancer
Other: educational intervention
Other: medical chart review
|Study Design:||Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Health Services Research
|Official Title:||Adherence to NCCN Survivorship Care Guidelines in Non-Small Cell Lung Cancer and Colorectal Cancer Survivor Care|
- Percentage of eligible CRC and NSCLC survivors with medical record documentation of compliance with NCCN guidelines [ Time Frame: Up to 6 months ]A test of the binomial proportion will have 99% power with 1% type I error to make this distinction.
- Change in percentage of eligible survivors with documentation of compliance with NCCN survivorship guidelines after conducting the targeted educational initiative at participating sites [ Time Frame: Baseline and up to 6 months ]This two-sample test of binomial proportions will have 99% power with 1% type I error.
|Study Start Date:||January 2013|
|Primary Completion Date:||July 2015 (Final data collection date for primary outcome measure)|
Experimental: Health services research (educational intervention)
Health care providers complete an educational intervention based on NCCN guidelines in CRC and NSCLC survivorship care comprising a power point presentation reviewing evidence and prompts for addressing survivorship care components; and an electronic paper copy sample survivorship care plan that can be adapted and distributed at each participating site.
Other: educational intervention
Complete an educational intervention based on NCCN guidelines and disease-specific issues related to survivorship care
Other Name: intervention, educationalOther: medical chart review
Complete patient medical chart audit
Other Name: chart review
I. To evaluate adherence of oncology health care providers to National Comprehensive Cancer Network (NCCN) guidelines for cancer survivorship care in colorectal cancer (CRC) and non-small cell lung cancer (NSCLC) cancers.
I. To develop and assess a targeted educational initiative to improve compliance with NCCN CRC and NSCLC survivorship guidelines for oncology health care providers in academic and community practice.
II. To evaluate the impact of this educational initiative on documented adherence and compliance with NCCN guidelines for NSCLC and CRC survivorship care by oncology health care providers.
Health care providers complete an educational intervention based on NCCN guidelines in CRC and NSCLC survivorship care comprising a power point presentation reviewing evidence and guidelines; a USB drive of the NCCN guidelines with paper copy of pages addressing survivorship care; an electronic and paper copy of a sample survivorship clinic template note with prompts for addressing survivorship care components; and an electronic paper copy sample survivorship care plan that can be adapted and distributed at each participating site.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01726296
|Contact: Crystal Denlinger, MDemail@example.com|
|United States, Pennsylvania|
|Fox Chase Cancer Center||Recruiting|
|Philadelphia, Pennsylvania, United States, 19111|
|Contact: Crystal Denlinger, MD 215-214-1676 firstname.lastname@example.org|
|Principal Investigator: Crystal Denlinger, MD|
|Principal Investigator:||Crystal Denlinger, MD||Fox Chase Cancer Center|